ONCOMATRYX, a Spanish biopharmaceutical company developing Quantum ADCs against the tumor microenvironment, has successfully raised $67 million to foster the clinical development of novel candidates.
The first Edge Security Management (ESM) to modernize 30-year-old legacy WAF technology, with TikTok and global brands as early enterprise customers ...
When we went AI-first in 2025, implementation cost collapsed. Agents took over scaffolding, tests, and the repetitive glue code that used to eat half the sprint. Cycle times dropped from weeks to days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results